Income Taxes - Deferred Tax Assets And Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Significant components of the Company's deferred tax assets and liabilities
Intangible assets		$ 1,197
Deferred revenue	$ 24,660	16,274
Interest expense	29,095	21,183
Other reserves and accruals	30,730	5,087
Tax credit carryforwards	10,249	5,613
Amortization of stock-based compensation	13,904	3,900
Non-Compensatory warrants	4,115	5,020
Capitalized research & development expenditures	42,525	35,353
Right of use liability (operating leases)	6,603	27,715
Net operating loss carryforwards	217,812	120,992
Total deferred tax asset	379,693	242,334
Valuation allowance	(313,868)	(171,594)
Net deferred tax assets	65,825	70,740
Intangible assets	(34,342)	(7,360)
Convertible debt	(27,346)	(27,420)
Right of use asset (operating leases)	(732)	(27,684)
Other reserves and accruals		(12)
Property, plant and equipment and right of use assets	(8,489)	(9,191)
Deferred tax liability	(70,909)	(71,667)
Net	(5,084)	(927)
U.S.
Significant components of the Company's deferred tax assets and liabilities
Deferred revenue	24,514	16,082
Interest expense	29,095	21,183
Other reserves and accruals	23,398	5,087
Tax credit carryforwards	8,960	4,360
Amortization of stock-based compensation	13,904	3,900
Non-Compensatory warrants	4,115	5,020
Capitalized research & development expenditures	37,912	30,870
Right of use liability (operating leases)	6,118	27,715
Net operating loss carryforwards	205,760	110,978
Total deferred tax asset	353,776	225,195
Valuation allowance	(295,424)	(154,467)
Net deferred tax assets	58,352	70,728
Intangible assets	(23,244)	(7,360)
Convertible debt	(27,346)	(27,420)
Right of use asset (operating leases)	(247)	(27,684)
Property, plant and equipment and right of use assets	(8,489)	(9,191)
Deferred tax liability	(59,326)	(71,655)
Net	(974)	(927)
Foreign
Significant components of the Company's deferred tax assets and liabilities
Intangible assets		1,197
Deferred revenue	146	192
Other reserves and accruals	7,332
Tax credit carryforwards	1,289	1,253
Capitalized research & development expenditures	4,613	4,483
Right of use liability (operating leases)	485
Net operating loss carryforwards	12,052	10,014
Total deferred tax asset	25,917	17,139
Valuation allowance	(18,444)	(17,127)
Net deferred tax assets	7,473	12
Intangible assets	(11,098)
Right of use asset (operating leases)	(485)
Other reserves and accruals		(12)
Deferred tax liability	(11,583)	$ (12)
Net	$ (4,110)